Benzinga (Sun, 21-Apr 5:45 PM ET)
Earnings week ahead: Tesla, Meta Platforms, Google, Microsoft, Intel, Exxon Mobil, and more
Seeking Alpha News (Sun, 21-Apr 8:00 AM ET)
VGK vs. EZU: Which Is the Better European Stock ETF?
TipRanks (Fri, 19-Apr 6:21 PM ET)
Tech advances are catalyzing the Health Care sector with improved investor sentiment - SSGA
Seeking Alpha News (Fri, 19-Apr 2:48 PM ET)
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Benzinga (Fri, 19-Apr 11:39 AM ET)
Business Wire (Tue, 16-Apr 8:00 AM ET)
Business Wire (Tue, 16-Apr 7:00 AM ET)
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Business Wire (Thu, 11-Apr 7:00 AM ET)
Business Wire (Fri, 5-Apr 11:10 PM ET)
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.
As of April 23, 2024, AZN stock price climbed to $70.94 with 3,882,517 million shares trading.
AZN has a beta of 0.57, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.12 to the broad based SPY ETF.
AZN has a market cap of $219.79 billion. This is considered a Mega Cap stock.
Last quarter Astrazeneca PLC - American Depositary Shares reported $12 billion in Revenue and $.73 earnings per share. This fell short of revenue expectation by $-66 million and missed earnings estimates by -$.07.
In the last 3 years, AZN stock traded as high as $76.56 and as low as $50.66.
The top ETF exchange traded funds that AZN belongs to (by Net Assets): QQQ, QQQM, FVD, PPH, TQQQ.
AZN stock has underperformed the market in the last year with a return of -4.3%, while SPY returned +24.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AZN shares. However, AZN has outperformed the market in the last 3 month and 2 week periods, returning +7.1% and +4.8%, while SPY returned +4.9% and -2.6%, respectively. This indicates AZN has been having a stronger performance recently.
AZN support price is $69.23 and resistance is $71.03 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN stock will trade within this expected range on the day.